Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
3
33%
Ph phase_4
1
11%
Ph not_applicable
4
44%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (37.5%)
Phase 41 (12.5%)
N/A4 (50.0%)

Trials by Status

completed889%
terminated111%

Recent Activity

0 active trials
Showing 5 of 9
completednot_applicable

Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance

NCT07371169
completedphase_4

Chromium and Insulin Action

NCT00283777
completedphase_1

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

NCT00109746
completednot_applicable

Effects of Chromium Picolinate on Food Intake

NCT00477854
completed

Novel Therapy for Glucose Intolerance in HIV Disease

NCT02006914
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07371169Not Applicable

Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance

Completed
NCT00283777Phase 4

Chromium and Insulin Action

Completed
NCT00109746Phase 1

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

Completed
NCT00477854Not Applicable

Effects of Chromium Picolinate on Food Intake

Completed
NCT02006914

Novel Therapy for Glucose Intolerance in HIV Disease

Completed
NCT00904306Phase 1

Binge Eating and Chromium Study

Completed
NCT00997659Not Applicable

Chromium's Effect on Insulin Resistance in Obesity

Completed
NCT00332085Phase 1

Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

Terminated
NCT00128154Not Applicable

Chromium Picolinate for the Treatment of Metabolic Syndrome

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9